drugset / Trial / NCT00247169

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

NCT00247169

Phase 2 Completed 40 enrolled Medical University of Vienna
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The investigators want to test whether treatment with a natural progesterone intravaginally increases the cure rate of cervical intraepithelial neoplasia grade I and II.

Timeline

Start
2004-08
Primary completion
2009-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 400 mg Other